FDA APPROVES FIRST GENE THERAPIES TO TREAT PATIENTS WITH SICKLE CELL DISEASE
The FDA approved the first two gene therapies, Casgevy and Lyfgenia, to treat sickle cell disease. These one-time treatments come with a hefty price tag.
The FDA approved the first two gene therapies, Casgevy and Lyfgenia, to treat sickle cell disease. These one-time treatments come with a hefty price tag.
Love addiction is an unhealthy attachment that can take over your life. Get help through therapy and support groups to build healthy relationships.
At-home DNA tests like 23andMe screen for limited gene mutations linked to breast cancer risk. A negative result doesn't rule out risk. Consider genetic counseling before using these tests